Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

SLXP 110.78 +0.83 (0.75%)
price chart
Salix Pharmaceuticals Ltd.: Salix Pharmaceuticals Announces 1Q2014 Financial ...
RALEIGH, NC, April 24, 2014 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report first quarter 2014 financial results following the close of the U.S.
Related articles »  
Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of ...
Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that the submission to the European Medicines Agency (EMA) of RELISTOR�(methylnaltrexone bromide) Subcutaneous Injection for the ...
Salix Pharmaceuticals Now Covered by Analysts at Sterne Agee (SLXP)
Salix Pharmaceuticals, Ltd. logo Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research note issued to investors on Wednesday, TheFlyOnTheWall.
Stocks Buzz- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), ZyngaInc (NASDAQ ...  Techsonian (press release)
Related articles »  
Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the ...
Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) and Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today that the submission to the European Medicines Agency (EMA) of RELISTOR(R)(methylnaltrexone bromide) Subcutaneous Injection for the ...
Get Quote Search Site  Investor's Business Daily
Related articles »  
Salix Pharmaceuticals Receives Average Recommendation of �Hold� from ...
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting ...
Related articles »  
Salix Pharmaceuticals Coverage Initiated at Jefferies Group (SLXP)
Salix Pharmaceuticals, Ltd. logo Jefferies Group started coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research report sent to investors on Monday morning, TheFlyOnTheWall.
Why Salix Pharmaceuticals (SLXP) Could Be a Potential Winner
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Salix Pharmaceuticals Ltd. (SLXP - Analyst Report). This specialty pharmaceutical company has actually seen estimates rise over the past month ...
Active Movers � Hercules Offshore, (NASDAQ:HERO), AutoNation, Inc. (NYSE ...  Techsonian (press release)
Related articles »  
Declarations in Focus: Salix Pharmaceuticals (NASDAQ:SLXP), Magnum Hunter ...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) [Trend Analysis] and Progenics Pharma (PGNX) reported that that the submission to the European Medicines Agency of RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of ...
Salix Pharmaceuticals Coverage Initiated by Analysts at Sterne Agee (SLXP)
Salix Pharmaceuticals, Ltd. logo Research analysts at Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a report released on Wednesday, TheFlyOnTheWall.
Stock's Buzzers- Salix Pharmaceuticals, Ltd. (SLXP), North American Palladium ...
... revenue surged 30% to $257.6 million. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) decreased -3.20% and closed at $104.99 in the last trading session with the overall traded volume of 1.67 million shares, versus the average volume of 1.19 million shares.